Article Details
Retrieved on: 2021-05-22 01:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Company's product candidates include, among others, PRV-031 teplizumab and monoclonal antibodies, in Phase III clinical trial for the ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here